TY - JOUR
T1 - Effects of Betaine in a Murine Model of Mild Cystathionine-β-Synthase Deficiency
AU - Schwahn, Bernd C.
AU - Wendel, Udo
AU - Lussier-Cacan, Suzanne
AU - Mar, Mei Heng
AU - Zeisel, Steven H.
AU - Leclerc, Daniel
AU - Castro, Carmen
AU - Garrow, Timothy A.
AU - Rozen, Rima
N1 - Funding Information:
Supported by grants from the Canadian Institutes for Health Research (CIHR) to R.R., Grant No.DK52501 from the National Institutes of Health (NIH) to T.A.G., and Grants No. DK55865, DK56350, and ES10126 from the NIH to S.H.Z. R.R. is a recipient of a Senior Scientist Award from the CIHR.
PY - 2004/5
Y1 - 2004/5
N2 - Cystathionine-β-synthase (CBS) is required for transsulfuration of homocysteine, an amino acid implicated in vascular disease. We studied homocysteine metabolism in mice with mild hyperhomocysteinemia due to a heterozygous disruption of the Cbs gene. Mice were fed diets supplemented with betaine or dimethylsulfonioacetate (DMSA); betaine and DMSA provide methyl groups for an alternate pathway of homocysteine metabolism, remethylation by betaine:homocysteine methyltransferase (BHMT). On control diets, heterozygous mice had 50% higher plasma homocysteine than did wild-type mice. Betaine and DMSA had similar effects in both genotype groups: liver betaine increased dramatically, while plasma homocysteine decreased by 40% to 50%. With increasing betaine supplementation, homocysteine decreased by 75%. Plasma homocysteine and BHMT activity both showed a strong negative correlation with liver betaine. Homocysteinemia in mice is sensitive to a disruption of Cbs and to methyl donor intake. Because betaine leads to a greater flux through BHMT and lowers homocysteine, betaine supplementation may be beneficial in mild hyperhomocysteinemia.
AB - Cystathionine-β-synthase (CBS) is required for transsulfuration of homocysteine, an amino acid implicated in vascular disease. We studied homocysteine metabolism in mice with mild hyperhomocysteinemia due to a heterozygous disruption of the Cbs gene. Mice were fed diets supplemented with betaine or dimethylsulfonioacetate (DMSA); betaine and DMSA provide methyl groups for an alternate pathway of homocysteine metabolism, remethylation by betaine:homocysteine methyltransferase (BHMT). On control diets, heterozygous mice had 50% higher plasma homocysteine than did wild-type mice. Betaine and DMSA had similar effects in both genotype groups: liver betaine increased dramatically, while plasma homocysteine decreased by 40% to 50%. With increasing betaine supplementation, homocysteine decreased by 75%. Plasma homocysteine and BHMT activity both showed a strong negative correlation with liver betaine. Homocysteinemia in mice is sensitive to a disruption of Cbs and to methyl donor intake. Because betaine leads to a greater flux through BHMT and lowers homocysteine, betaine supplementation may be beneficial in mild hyperhomocysteinemia.
UR - http://www.scopus.com/inward/record.url?scp=2342501877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342501877&partnerID=8YFLogxK
U2 - 10.1016/j.metabol.2003.10.033
DO - 10.1016/j.metabol.2003.10.033
M3 - Article
C2 - 15131763
AN - SCOPUS:2342501877
SN - 0026-0495
VL - 53
SP - 594
EP - 599
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 5
ER -